Fachliteratur Gastroenterologie: Neoplasien der Leber

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Leber » Neoplasie

19. April 2025

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3573


	Artikel 1 - 20 / 71443

	Immune therapies in intermediate-advanced unresectable hepatocellular carcinoma: Changing the therapeutic landscape. World J Gastroenterol Biswas S, Samanta A. PMID: 40248376 [PubMed - indexed for MEDLINE]
	Diagnostic and prognostic performance of serum GPC3 and PIVKA-II in AFP-negative hepatocellular carcinoma and establishment of nomogram prediction models. BMC Cancer Lin Y, Ma Y, Chen Y, Huang Y, Lin J, Xiao Z, Cui Z. PMID: 40247208 [PubMed - indexed for MEDLINE]
	Prognostic analysis of patients with CRLM based on CRS score: a single-center retrospective study. BMC Cancer Xue JS, Maimaitiming N, Zhang BL, Xu BW, Yin X, Huang Z, Che X, Zhao H, Cai JQ. PMID: 40247181 [PubMed - indexed for MEDLINE]
	Human leukocyte antigen-G in hepatocellular carcinoma driven by chronic viral hepatitis or steatotic liver disease. Sci Rep Mocci S, Perra A, Littera R, Pes F, Melis M, Sanna C, Mascia A, Murgia M, Mereu C, Lorrai M, Du, Zedda G, Lai S, Giuressi E, Guarino F, Serra G, Miglianti M, Stradoni R, Vacca M, Zolfino T, Chessa L, Giglio S. PMID: 40246934 [PubMed - indexed for MEDLINE]
	Surgical Resection Versus Microwave Ablation for Colorectal Liver Oligometastases: A Multicenter Cohort Study of 1027 Patients. J Gastrointest Cancer Li B, Li L, Ren H. PMID: 40244487 [PubMed - indexed for MEDLINE]
	Potential role of endothelial dysfunction in hypertension and proteinuria in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab: a pilot prospective observational study. Cancer Chemother Pharmacol Nihei S, Saito K, Ikeda T, Oikawa T, Asahi K, Asaka J, Kudo K. PMID: 40244305 [PubMed - indexed for MEDLINE]
	Geographic and Viral Etiology Patterns of TERT Promoter and CTNNB1 Exon 3 Mutations in Hepatocellular Carcinoma: A Comprehensive Review. Int J Mol Sci Terra ML, Sant'Anna TBF, de Barros JJF, de Araujo NM. PMID: 40243493 [PubMed - indexed for MEDLINE]
	Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances. Front Immunol Xie D, Liu Y, Xu F, Dang Z, Li M, Zhang Q, Dang Z. PMID: 40242773 [PubMed - indexed for MEDLINE]
	The role of TACE in the era of immune-targeted therapy for hepatocellular carcinoma: a meta-analysis based on PSM. Front Immunol Li J, Xian L, Wang X, Liu Y, Li J. PMID: 40242754 [PubMed - indexed for MEDLINE]
	Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma. Clin Mol Hepatol Kim DW, Park JH, Hong SK, Jung MH, Pyeon JO, Lee JY, Suh KS, Yi NJ, Choi Y, Lee KW, Kim YJ. PMID: 40241383 [PubMed - indexed for MEDLINE]
	Comparative efficacy of tislelizumab plus lenvatinib and tislelizumab alone against advanced hepatocellular carcinoma after lenvatinib failure: a real-world study. BMC Cancer Yang J, Xu Q, Luo S, Wu J. PMID: 40240993 [PubMed - indexed for MEDLINE]
	Different cutoff values of the skeletal muscle mass and myosteatosis result in different clinical impact on overall survival in oncology. A subanalysis of a clinical trial. J Cancer Res Clin Oncol Surov A, Thormann M, Wienke A, Ricke J, Seidensticker M. PMID: 40240716 [PubMed - indexed for MEDLINE]
	Predicting tumor dynamics in treated patients from patient-derived-xenograft mouse models: a translational model-based approach. J Pharmacokinet Pharmacodyn Ronchi D, Tosca EM, Magni P. PMID: 40240647 [PubMed - indexed for MEDLINE]
	Risk of hepatocellular carcinoma and cirrhosis decompensation in a large retrospective cohort of cirrhotic patients with autoimmune hepatitis. Sci Rep Tatour M, Zuckerman E, Abu-Freha N, Hazzan R. PMID: 40240433 [PubMed - indexed for MEDLINE]
	The Effect of MAFLD on Hepatocarcinogenesis in HBeAg-negative Patients with Undetectable HBV-DNA under NA Therapy: A Multicenter Study. Intern Med Amano K, Sano T, Ide T, Nakano D, Tsutsumi T, Arinaga-Hino T, Kawaguchi M, Hirai S, Miyajima I, Torimura T, Kawaguchi T. PMID: 40240151 [PubMed - indexed for MEDLINE]
	Palliative and supportive care in patients with hepatocellular carcinoma: a qualitative study on attitudes and perceptions of health professionals. Support Care Cancer Gofton C, Bartolomeo AD, Wijekulasuriya S, Cai S, Boutros R, Stafford-Bell F, Caldwell K, McCaughan G, Zekry A, Strasser SI, Levy M, Sheehan C, Goodall S, Davis JM, Sheahan L, Liu K, Greenaway S, Davison S, Huynh TD, Quadri Z, Zurynski YA, Agar M, George J. PMID: 40237862 [PubMed - indexed for MEDLINE]
	Comprehensive Analysis of Oncogenic, Prognostic, and Immunological Roles of FANCD2 in Hepatocellular Carcinoma: A Potential Predictor for Survival and Immunotherapy. Biomed Environ Sci Xu MJ, Deng W, Jiang TT, Wang SY, Liu RY, Chang M, Wu SL, Shen G, Chen XX, Gao YJ, Hao H, Hu LP, Zhang L, Lu Y, Yi W, Xie Y, Li MH. PMID: 40237267 [PubMed - indexed for MEDLINE]
	A nomogram for prognostic prediction and for therapeutic decision making of elderly HCC patients. BMC Gastroenterol Liu S, Zhou M, Chen P, Deng X, Gu J, Miao L. PMID: 40234755 [PubMed - indexed for MEDLINE]
	Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab - the FAB-HCC pilot study. PLoS One Pomej K, Frick A, Scheiner B, Balcar L, Pajancic L, Klotz A, Kreuter A, Lampichler K, Regnat K, Zinober K, Trauner M, Tamandl D, Gasche C, Pinter M. PMID: 40233040 [PubMed - indexed for MEDLINE]
	Evaluation of hepatic cancer stem cells (CD(73+), CD(44+), and CD(90+)) induced by diethylnitrosamine in male rats and treatment with biologically synthesized silver nanoparticles. Mol Biol Rep Pervez A, Khan B, Khan GN, Khattak S, Ali M, Mujeeb K, Nasib B, Kim HG, Qureshi IZ, Arshad M. PMID: 40232523 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 71443

Seite 1 von 3573



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung